Markets › United States › NAS › CSTL

Castle Biosciences Inc

NAS:CSTLHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$32.17+0.64%At closeAt close · Tue 20 Oct · ≈ AED 118.13 · Market cap $982.62M · Next earnings Mon 2 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	84.5%	83.2%	76.6%	79.5%	81.9%	79.4%	—	—
Operating margin	−10.4%	−42.6%	−53.2%	−30.9%	2.6%	−12.4%	−12.4%	+0.0 pts
Net margin	−16.4%	−33.3%	−49.0%	−26.1%	5.5%	−7.0%	−7.0%	+0.0 pts
EBITDA margin	−11.3%	−38.9%	−42.6%	−20.5%	11.5%	3.3%	—	—
Return on equity	−2.5%	−7.6%	−16.8%	−14.7%	4.0%	−5.1%	−5.1%	+0.0 pts
Return on assets	−2.3%	−6.8%	−15.0%	−12.7%	3.4%	−4.2%	−4.2%	+0.0 pts
Return on capital employed	−1.6%	−9.2%	−17.7%	−16.8%	1.8%	−8.4%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	0.0%	1.8%	3.0%	3.4%	5.0%	6.4%	—	—
Interest coverage	−2.5×	−40,079.0×	−4,285.6×	−6,179.7×	15.0×	−497.8×	—	—
Current ratio	20.6×	14.2×	8.1×	6.2×	7.3×	5.3×	5.3×	+0.0%
Quick ratio	20.5×	14.1×	8.0×	6.0×	7.1×	5.1×	—	—
Cash ratio	19.6×	13.2×	3.4×	2.1×	2.4×	1.7×	1.7×	+0.0%
Asset turnover	0.1×	0.2×	0.3×	0.5×	0.6×	0.6×	—	—
Inventory turnover	4.4×	7.8×	8.0×	5.7×	7.4×	6.9×	—	—
Receivables turnover	4.9×	5.4×	5.8×	5.7×	6.5×	7.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—